COTA expands clinicogenomics offering with Genomic Testing Cooperative partnership.

Thanks for reaching out

We will be in-touch shortly. In the meantime, check out some of the recent posts.

The two companies are joining forces to integrate COTA’s deep clinical oncology real-world data with GTC’s comprehensive genomics testing data.

In Move to Power Precision Oncology for Patients, COTA and Genomic Testing Cooperative Form New Data Partnership

The two companies are joining forces to integrate COTA’s deep clinical oncology real-world data with GTC’s comprehensive genomics testing data.

COTA, Inc. Forms Strategic Real-World Data Research Partnership with the Clinical Research Data Sharing Alliance

COTA, Inc. is now a proud member of the Clinical Research Data Sharing Alliance (CRDSA). This cross-industry alliance is dedicated to accelerating the discovery and delivery of life-saving therapies through the use of high-quality clinical trials and real-world data.

What Makes a Fit-for-Purpose Database for Clinical Oncology Research?

A fit-for-purpose database includes key variables, reliable and accurate data, and representative samples that can be used to draw meaningful conclusions. RWD can be highly valuable in supporting clinical oncology research, but choosing the right data is essential. The keys to finding the right fit-for-purpose database include relevance, reliability, integrity, and bias.

Subscribe for Updates

Receive our latest news and research from thought leaders in the RWD industry
  • This field is for validation purposes and should be left unchanged.